Settlement with GHFG

Source: RNS
RNS Number : 7828K
Clean Power Hydrogen
04 November 2024
 

 

4 November 2024                                                                                     

Clean Power Hydrogen plc

("CPH2", the "Company" or the "Group")

Settlement with GHFG

CPH2, the UK-based green hydrogen technology and manufacturing company that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), GHFG Limited ("GHFG"), initially disclosed on 6 June 2023.

All parties have agreed to settle and resolve matters amicably, with no admission of fault. Under the terms of the settlement, the Company will not claim nor pay any damages and all legal action will be terminated by both parties. As stated on 6 June 2023, the licence agreement with GHFG had already been terminated.

 

 

For more information, please contact:

 

 

To find out more, please visit: https://www.cph2.com

 

Overview of CPH2

 

CPH2 is the holding company of Clean Power Hydrogen Group Limited which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBJBMTMTIMTMI